Clinical Trial Update: Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing double-dose versus single-dose sirolimus-eluting stents in diabetic patients with de novo coronary artery lesions completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED